Paul Murray, Swiss Re's CEO of Life & Health Reinsurance, commented on these findings in a press release, noting that GLP-1 drugs hold "significant promise to help us beat the obesity epidemic." CLICK HERE TO GET THE FOX NEWS APP "Our research underscores that the full benefit will come from going beyond medication," he wrote
Saturday Balances flexibility and control
Therefore, we focus on the biological characteristics of GLP-1, render an overview of the mechanism of GLP-1 effects in diseases, and investigate the potential of GLP-1 analogues for the treatment of related diseases in this review
(Reference Calvi, Quassolo, Massaia, Scandurra, D'Aniello and D'Amelio2020) but may also be requested from the corresponding author
The 10mg vial is designed for extended research protocols or dose-escalation studies requiring higher quantities